Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES

Benzer Materyaller

• Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?
  Yazar:: Ferraccioli, Gianfranco, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
  Yazar:: Alivernini, Stefano, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression
  Yazar:: Bosello, Silvia, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission
  Yazar:: Alivernini, Stefano, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Memory B cell subsets and plasmablasts are lower in early than in long-standing Rheumatoid Arthritis
  Yazar:: Fedele, Anna Laura, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)